Responses
Regular and young investigator award abstracts
Novel single-agent immunotherapies
715 FS118, a tetravalent bispecific antibody targeting LAG-3 and PD-L1, induces LAG-3 shedding resulting in receptor downregulation by T cells via a novel mechanism of action
Compose a Response to This Article
Other responses
No responses have been published for this article.
